Home
Up
What's New
News
What To Do First
On Line Support List
Proven Treatments
Potential Treatments
Symptoms Mgmt
Diagnostic Tests
Information Resources
FAQ

Support HRPCa.org

 

 

 

Update on Jack's Experience with Provenge Vaccine Trial

as of July 5, 2002


 

 

Hi All:

 

Here is my experience to date with the Phase III trial for Dendreon's Provenge vaccine based on my own dendritic cells. 

 

I was accepted for trial participation in December, 2001 and had baseline tests on December 27 & 28.  The "therapy" phase (described at the above site) began on 1/8/02 and was completed on 2/7/02.

 

Date Test Notes
     
12/18/01 PSA 44.1  last local test before starting trial - up from 34.5 on 10/15
12/27/01 CT scans "No evidence of  recurrent or metastatic neoplasm."
Bone Scan 

"Intense increased uptake is seen in the left scapula. It is extremely hot."  Other "moderately intense uptake" areas noted.                                                       Also noted that which might be degenerative or metastatic.

12/28/01

PSA 42.8

PAP 2.8

Covance CLS -- the trial lab. (Difference probably due to differing lab assays.)
2/19/02 PSA 47.7 local lab
2/28/02 Bone scan 

"Interval improvement of several of the areas of increased activity since previous exam of 12/27 suggesting interval improvement in the metastatic disease.  No new areas identified to suggest progression."

4/23/02 PSA 70.2 local lab
5/15/02 PSA 125.8, PAP 5.8 Covance CLS lab
Bone Scan

Compared to the prior study of 2/28/02, the current study shows increased tracer activity in the left scapula and at T7.  These may represent disease progression or due to  chemotherapy flair (if chemo received within 3-6 months).  There are no new focal abnormalities that are suspicious for metastatic disease.  [I'm assuming the "chemo" to be the vaccine infusions.  /jb]

6/25/02 PSA 98.3 Local lab

 

 

Next bone scan will be Monday, 7/8/02.  I will probably have the report within a couple of weeks after that, if I bug them enough.  :-)

 

Dendreon doesn't rely on PSA as a marker, but only progression as shown by scans and (I guess) other indicators.  In fact, they said that the PSA would rise initially because the immune system activity would mean many dead cancer cells (with PSA) would be circulating in the blood and thus show up on tests.

 

Because our local lab showed a higher PSA than the Covance base line, I consider that the latest local PSA being 20% lower than the Covance May PSA to be a positive sign.  Physically, I still feel fine with no actual pain and no discomfort that I can attribute to cancer.

 

Technically, I don't really know whether I received the real vaccine or a placebo, but I think it must have been the real stuff. 

 

FWIW, I understand that of the trial participants at the Columbus, OH test site, I was the 2nd to show any regression (which may now have turned around since then), but several had shown stability.

 

My tea tag this afternoon reads:  "What is wrong for one person may be

right for another."

 

My best,

/jack

~~~~~~~~~~~~~~~~~~~~~~~~~~~

** Jack Beaven  **  Dayton, Ohio **

****  MahlonBeav@juno.com  ****

**10 year Prostate Cancer survivor **

~~~~~~~~~~~~~~~~~~~~~~~~~~~



[Top]


 

This information is provided for educational purposes only and does not replace or amend professional medical advice. Unless otherwise stated and credited, the content of www.hrpca.org is by and the opinion of and copyright © 2001-2008 by H. Hansen. All Rights Reserved.  Our policy regarding privacy,  right to reprint and contact information are at About Us. We are a 501(c)(3) not-for-profit public charity.